Scientists at McMaster University have discovered several new biomarkers from a single drop of blood that could allow earlier and more definitive detection of cystic fibrosis (CF), a genetic disease which strikes both children and adults, causing chronic problems with the digestive system and the lungs.
The findings, published online in the Journal of Proteome Research, are significant because current newborn screening methods are not accurate enough to identify the disorder in the population, which can manifest itself in many different ways, requiring additional testing and causing further stress for anxious parents.
“The earlier CF is detected, the earlier it can be managed and treated, which means better health outcomes for affected infants, including their future growth and development,” says Philip Britz-McKibbin, lead author of the study and a professor in McMaster’s Department of Chemistry & Chemical Biology, who conducted the research with graduate student Alicia DiBattista, now a postdoctoral fellow at Newborn Screening Ontario (NSO).
A tiny amount of blood is drawn from the heel of all babies as part of universal newborn screening programs that test for many rare yet treatable diseases since babies usually have no signs of disease at birth, including CF.
In the case of CF, infants are screened for a pancreatic enzyme and then a panel of disease-causing genetic mutations associated with CF. However, further testing to confirm or rule out the disease finds that most babies who screen-positive do not actually have the disease. These babies are later found to be “healthy carriers” or their results are deemed to be “false positives”.
With this in mind, researchers set out to determine whether they could discover chemical signatures in a dried blood spot that could better distinguish infants who have CF from those who do not.
Using less than a single drop of blood stored at NSO at CHEO, a pediatric health and research centre in Ottawa, researchers analyzed and compared samples from infants confirmed to have CF with the samples of both healthy and screen positive infants. They found several new compounds as well as simple amino acids directly related to affected infants with CF who otherwise have no symptoms and normal birth weight.
“These biomarkers provide new insights into the disease process early in life before symptoms are fully apparent,” says Britz-McKibbin. “Moreover, these compounds can be analyzed by mass spectrometry at incremental costs since it is already used for testing many other genetic diseases at newborn screening facilities around the world”
“Ontario started screening for Cystic Fibrosis in April 2007, and since that time over 400 children have already benefited from early recognition and early treatment. But for every one of these children, about 10 have had a false-positive result. We want to get this number down and are very hopeful that the new biomarkers discovered by this research project will help us do exactly that,” says Pranesh Chakraborty, medical director of NSO at CHEO.
In Canada, life expectancy rates have risen dramatically with the median age of survival now over 50 years, due to better treatments to improve lung function, better nutrition, lung transplants. The advent of universal newborn screening programs for CF will likely further improve the quality of life of affected patients.
“We know that early detection can have significant benefits for people living with cystic fibrosis,” said Dr. John Wallenburg, chief scientific officer at Cystic Fibrosis Canada. “The current screening methodologies capture a broad swathe of families that then need further testing to narrow down those that are true positives. The anxiety and distress that such further testing can needlessly cause families was a major concern that slowed the adoption of newborn screening in some jurisdictions. Dr. Britz-McKibbin’s data provide insights for more specific newborn screening, as well as early manifestations of the disease.”
Learn more: Identifying cystic fibrosis earlier and more reliably
The Latest on: Cystic fibrosis
[google_news title=”” keyword=”cystic fibrosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Cystic fibrosis
- Ashes of American woman flown 5000 miles for burial on Isle of Skyeon April 27, 2024 at 8:30 pm
A woman who fought a lifelong battle against cystic fibrosis had her ashes flown 5000 miles from California for a burial ceremony on her beloved Isle of Skye.
- Great Strides raises more than $64K for cystic fibrosis researchon April 27, 2024 at 1:30 pm
More than $64,000 was raised during the 23rd annual Great Strides Walk and 21st annual 65 Roses 5K, which were held last month to raise money for the Cystic Fibrosis ...
- Life transformed for five-year-old... all thanks to wonder cystic fibrosis drugon April 27, 2024 at 6:38 am
EXCLUSIVE: Last year mum Chloe Browne feared her five year-old's cystic fibrosis was slowly destroying his health - but it's all changed after taking wonder pill kaftrio.
- $100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugson April 26, 2024 at 11:34 am
Vertex Pharmaceuticals Inc‘s (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite ...
- Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Olderon April 26, 2024 at 8:43 am
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of ...
- Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisison April 26, 2024 at 2:00 am
The number of people living with CF worldwide is now 105,000, up from 70,000 in 2012, according to estimates from US non-profit the Cystic Fibrosis Foundation — a rise that experts attribute both to ...
- Woman with cystic fibrosis can’t believe she managed to run 26.2 mileson April 23, 2024 at 11:05 pm
A WOMAN with cystic fibrosis ran the London Marathon thanks to “miracle” drugs. Nell Summerley, 21, from Britwell Salome, took part in Sunday’s race to raise money for the Cystic Fibrosis Trust. She ...
- Vertex has top orphan asset in the pipeline, as pharma eyes shiny obesity drugs: reporton April 23, 2024 at 9:00 pm
Vertex’s cystic fibrosis triple combo is poised to become the top selling orphan drug in terms of net present value, amid shifting sentiments in the pharma industry for rare disease drugs, according ...
- Arcturus Therapeutics' ARCT-032: Might Be The Next Breakthrough In Cystic Fibrosison April 23, 2024 at 3:01 am
Arcturus Therapeutics is on the verge of obtaining regulatory approvals for two gene therapies targeting rare diseases. See why ARCT stock is a Buy.
- Southend woman with cystic fibrosis to make world record marathon attempton April 20, 2024 at 10:03 pm
A woman with cystic fibrosis is is lacing up to set a new world record by running 36 marathons in 36 days. Sophie Holmes, from Southend-on-Sea, was told her cystic fibrosis (CF) meant she would not ...
via Bing News